Intel Corp. (INTC) Gets 23% Boost on US Govt Backing
Shares of Intel Corp. jumped by 23.1 percent week-on-week as investors took heart from the US government's potential financial backing in a bid to support the long beleaguered chipmaker.
After taking a swipe at Intel Corp. (NASDAQ:INTC) earlier this month, calling the company's CEO, Lip-Bu Tan, to resign immediately, President Donald Trump appeared to have taken a U-turn following a meeting, saying it was 'a very interesting one.'
'His success and rise is an amazing story,' Trump said about Tan.
Reportedly, the US government was ready to provide support to the chipmaker by acquiring a significant stake in its stock.
Citing people familiar with the matter, Bloomberg said the government was considering tapping funds from the 2022 CHIPS Act.
Intel Corp. (NASDAQ:INTC), once the largest chipmaker globally, struggled over the past few decades amid the intensifying competition in the industry and the changing corporate visions from its previous leaders.
Last year, Intel Corp. (NASDAQ:INTC) officially announced plans to embark on a corporate restructuring plan in a bid to claw back to profitability. The initiative included the reduction of at least 15 percent of its total workforce, reducing operating expenses and capital expenditures, and exiting businesses to raise funds, among others.
While we acknowledge the potential of INTC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the .
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Investors see risks for market as Powell walks tightrope at Jackson Hole
By Davide Barbuscia NEW YORK (Reuters) -Investors are bracing for volatility as Federal Reserve Chair Jerome Powell walks a fine line between curbing inflation and supporting the labor market, with thin August trading poised to magnify any market moves from his Jackson Hole speech on Friday. Wall Street largely expects Powell will signal an imminent easing in monetary policy, but concerns that U.S. President Donald Trump's tariffs could reignite price pressures may force him to tread carefully. Meanwhile, Powell faces relentless pressure from the Trump administration to cut interest rates, turning his final address as Fed boss at the Jackson Hole economic symposium into a test of Fed independence. "There is a market tightrope here from a macroeconomic perspective between the inflation data and what's happening in the employment market," said Tony Rodriguez, head of fixed income strategy at Nuveen. "And now you combine that with the political tightrope that's not usually there that he has to navigate. It makes for an incredibly difficult, tricky situation," he said. Adding to the drama, Trump on Wednesday urged Fed Governor Lisa Cook to resign over mortgage allegations raised by one of his political allies, intensifying his effort to gain influence over the U.S. central bank. Cook said she had "no intention of being bullied" out of her post. "This (Jackson Hole) would be a good opportunity for Powell to speak about the importance of independence," said Idanna Appio, portfolio manager at First Eagle Investments, noting that the pressure could eventually lead to a more dovish rate-setting Fed board. A soft July jobs report and hefty downward revisions to earlier job figures fueled bets the U.S. central bank would cut interest rates from the current 4.25%-4.5% range later this year. But a surge in wholesale prices in July dimmed investor hopes for a half-point move at the Fed's next rate-setting meeting in September, leaving markets braced for about two 25 basis point cuts for the rest of the year. So far, consumers have been spared a sharp jump in prices despite Trump's escalating import tariffs, but doubts linger over how much of those duties will filter through to households in the months ahead. "I expect that Powell will signal a change in monetary policy that suggests that we'll resume the rate-cutting cycle on September 17, and markets will welcome that news," said Michael Arone, chief investment strategist at State Street Investment Management. "But I think he'll be reluctant to give too much transparency on the future path of rate cuts, because he knows what he doesn't know," Arone said, referring to the inflationary impact of tariffs. 'EXPECT VOLATILITY' Investors see any pushback from Powell against an imminent shift to monetary policy easing as the biggest risk heading into the Jackson Hole, Wyoming, event, with poor liquidity in summer trading expected to exacerbate the market reaction. "It's next to the last week of August, it's Friday, markets might be a little more susceptible to some volatility as a result of a little bit less liquidity ... (this) might lead to something of an unexpected move," said Rodriguez at Nuveen. Powell's speech comes amid market concerns of stagflation, a dreaded mix of sluggish growth and sticky inflation that could limit the Fed's ability to ride to Wall Street's rescue, just as a tech stock selloff this week highlighted long-standing worries over steep stock valuations. "Stagflation is a risk," said James Ragan, co-chief investment officer and director of investment management research at D.A. Davidson. "If Powell pulls back on the expectation for a rate cut in September, I think stocks would fall in that scenario and you obviously would see probably bond yields rise at least at the short end," he said. To be sure, Powell's address may ultimately be underwhelming for markets. Hot producer prices data in July removed the possibility that the Fed could deliver a jumbo-sized cut in September, limiting the scope for resistance from an inflation-focused Powell against those expectations. At the Jackson Hole conference in 2022, Powell echoed late Fed chair Paul Volcker with a hardline vow to crush inflation. This time, with inflation about 1 percentage point above the Fed's 2% target and a softening but still healthy job market, a subtler balance could be in the cards. Still, a balanced message could be perceived as hawkish, sparking price fluctuations in stocks and bonds over the next few weeks, said Shannon Saccocia, chief investment officer for wealth management at Neuberger Berman. "Our advice to clients has been to expect volatility," she said.
Yahoo
24 minutes ago
- Yahoo
Did I just father a meme coin? Well, accidentally…
Did I just father a meme coin? Well, accidentally… originally appeared on TheStreet. Okay, I'll tell you what happened. Last month, I was writing an article about Pudgy Penguins — the NFT collection turned Walmart toy success story, known across crypto circles. It was a pretty normal day. The piece was supposed to highlight how Pudgy Penguins, against all logic, had outperformed Bitcoin that week in sheer price action. But instead of calling it "Pudgy Penguins" throughout, I used the phrase 'Walmart toy coin.' Why? Because you can literally walk into Walmart, buy a Pudgy Penguin toy, scan a QR code, and unlock an NFT. It felt accurate. It felt fun. It was just one line. That was it — the line that started it all. Apparently, calling something a Walmart toy coin is meme gold. Within hours, an X (formerly Twitter) community popped up. Someone forked a coin. They actually called it 'Walmart Toy Coin.' And no — this isn't a shill. This is just a first-hand account of what happens when the crypto trenches take a throwaway joke and run with it. To be clear: I didn't launch it. I didn't fund it. I didn't promote it. In fact, we never editorialized that phrase in follow-ups because we knew how wild things can get. But still, it happened. On that day, the newly minted "Walmart Toy Coin" was up 50%, data from DEXScreener showed. Market cap hit half a million dollars at its peak. As of writing this, it's back down to $38,000, as most meme coins go. But the community? Still hanging on. Memes are still flying. So... did I just father a meme coin? This is the kind of weird stuff only crypto can make happen. The speed, the spontaneity, the utter chaos of it all. It's funny, but also kind of telling. Anything—anything—can become a coin. A passing phrase. A tweet. A typo. If enough people think it's funny, or relatable, or ironic, they'll ape in. The coin isn't the product. The vibe is the product. We're in an age where making a coin is easier than ever. With platforms like you can launch a Solana-based token in a few clicks. No code needed. According to CoinGecko, of the nearly 7 million cryptocurrencies listed since 2021, 3.7 million have since stopped trading and are considered failed. It means over 50% of all cryptocurrencies have failed. But a handful spark. And when they do, they take on a life of their own. Communities form. Telegrams explode. Memes multiply. And suddenly you're staring at a microculture that didn't exist a day ago. And while Ethereum meme coins have been on a tear lately, it's worth noting that the success rate is still vanishingly low. For every $PEPE or $DOGE, there are 10,000 coins that never even see a chart. What makes one catch on? No one really knows. A good name helps. A good joke helps more. But timing, virality, and tribal momentum? That's the secret sauce. Walmart Toy Coin is a perfect example. It was never meant to exist. It was a throwaway line in a fun market recap. But that's the crypto internet for you — everything's remixable. Your analysis might be someone else's next Ponzi. Your joke might be someone else's LP. It's chaotic, it's dumb, and it's also a case study in how memes move markets. Honestly, the entire experience gave me a bit of insight into how meme culture works in the trenches. It's not about fundamentals. It's about being first, being funny, and being fast. Communities don't wait for permission. If they like the vibe, they'll mint the coin. And if it pumps, even for a day, that's enough. So yeah. I might have accidentally fathered a meme coin. No roadmap. No team. No utility. Just a phrase, a story, and a whole lot of copy-paste culture. The coin's probably headed to zero. But the memes? They'll live forever. That's just crypto. Disclaimer: The views expressed in this op-ed are those of the author and do not necessarily reflect the views of TheStreet or its affiliates. This piece is for informational purposes only and should not be considered investment advice. As mentioned above, our team didn't create, launch, fund, or promote the "Walmart Toy Coin." Did I just father a meme coin? Well, accidentally… first appeared on TheStreet on Aug 21, 2025 This story was originally reported by TheStreet on Aug 21, 2025, where it first appeared. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24 minutes ago
- Yahoo
Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years
Achieve Life Sciences Inc. (NASDAQ:ACHV) is moving closer to a pivotal moment as it seeks FDA approval for cytisinicline, a potential first new smoking cessation therapy in nearly two decades, positioning the company for a high-stakes commercial launch in 2026. In a vote of confidence for the late-stage specialty pharmaceutical company's pipeline with a focus on smoking health and nicotine dependence, HC Wainwright has initiated coverage on Achieve Life Sciences with a Buy rating and a $12 price forecast. In June, Achieve Life Sciences submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for cytisinicline for nicotine dependence for smoking cessation in cytisinicline NDA is supported by a combination of efficacy and well-tolerated safety results from two Phase 3 trials, ORCA-2 and ORCA-3, which evaluated cytisinicline for smoking cessation. In both studies, cytisinicline administered for 6 or 12 weeks, alongside standard behavioral support, demonstrated significantly greater abstinence rates by the end of treatment and long-term abstinence through week 24 compared to placebo. The company has also included safety data on over 300 participants with at least six months of cumulative cytisinicline exposure. In June, the company raised around $45 million to fund continued advancement of cytisinicline through potential FDA marketing approval of cytisinicline and for working capital and general corporate purposes. The company expects the funding to provide runway into the second half of 2026. Analyst Brandon Folkes says, 'With the New Drug Application (NDA) now submitted, and a potential FDA approval and commercial launch in 2026, we view the next 12 to 18 months as a period of potential significant value inflection for ACHV stock.' Achieve Life Sciences' shares undervalue the commercial potential of cytisinicline, given the shortcomings of current therapies, rising smoking and vaping rates, and its superior efficacy and tolerability versus Pfizer Inc.'s (NYSE:PFE) Chantix (varenicline) and generics. Folkes sees tolerability as a key edge for cytisinicline, noting varenicline's side effects have limited its use. He argues that Achieve Life Sciences' valuation fails to capture the strong NDA data or the sizable market opportunity, where peak sales could far exceed the company's current worth. According to an investor note from Folkes, a rational pricing strategy for cytisinicline, potentially ranging from $500 to $3,000 per month, could be justified by the significant health economic costs associated with smoking. Cytisinicline could become the first FDA-approved smoking cessation therapy in nearly 20 years, with a U.S. launch expected in 2026. Its differentiated profile, flexible dosing, and broad adoption potential position it well in a $13 billion global market. Before its withdrawal, Pfizer's Chantix generated nearly $1 billion annually in U.S. sales, highlighting the sizable opportunity relative to Achieve's current valuation. Price Action: ACHV stock is trading higher by 14.92% to $2.97 at last check Thursday. Image via Shutterstock Latest Ratings for ACHV Date Firm Action From To Oct 2021 Alliance Global Partners Initiates Coverage On Buy Jun 2021 Oppenheimer Initiates Coverage On Outperform Sep 2020 Lake Street Initiates Coverage On Buy View More Analyst Ratings for ACHV View the Latest Analyst Ratings Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio
